Methods and compositions for treating melanoma
US-2024424002-A1 · Dec 26, 2024 · US
Vasoprotective and cardioprotective antidiabetic therapy
US9034883B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9034883-B2 |
| Application number | US-201113295174-A |
| Country | US |
| Kind code | B2 |
| Filing date | Nov 14, 2011 |
| Priority date | Nov 15, 2010 |
| Publication date | May 19, 2015 |
| Grant date | May 19, 2015 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The present invention relates to certain DPP-4 inhibitors for treating and/or preventing oxidative stress, vascular stress and/or endothelial dysfunction as well as to the use of such DPP-4 inhibitors in treatment and/or prevention of diabetic or non-diabetic patients, including patient groups at risk of cardiovascular and/or renal disease.
First claim
Opening claim text (preview).
The invention claimed is: 1. A method for treating oxidative stress, vascular stress and/or endothelial dysfunction in a sepsis patient in need thereof, the method comprising administering linagliptin to the patient. 2. The method of claim 1 , wherein the sepsis patient is a diabetic patient or a nondiabetic patient. 3. A method for treating sepsis comprising administering linagliptin to a patient in need thereof. 4. The…
Assignees
Inventors
Classifications
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9034883B2 cover?
- The present invention relates to certain DPP-4 inhibitors for treating and/or preventing oxidative stress, vascular stress and/or endothelial dysfunction as well as to the use of such DPP-4 inhibitors in treatment and/or prevention of diabetic or non-diabetic patients, including patient groups at risk of cardiovascular and/or renal disease.
- Who is the assignee on this patent?
- Klein Thomas, Daiber Andreas, Johansen Odd-Eric, and 4 more
- What technology area does this patent fall under?
- Primary CPC classification A61K31/519. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue May 19 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).